MEDICINES CO's ticker is MDCO and the CUSIP is 584688105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,744,000 | +77.5% | 312,700 | +33.8% | 0.66% | +18.8% |
| Q3 2019 | $6,052,000 | +86.0% | 233,708 | +8.8% | 0.55% | +83.7% |
| Q2 2019 | $3,253,000 | +49.4% | 214,808 | +14.6% | 0.30% | +33.8% |
| Q1 2019 | $2,177,000 | +2764.5% | 187,400 | +849.4% | 0.22% | +3114.3% |
| Q4 2018 | $76,000 | +81.0% | 19,739 | +43.2% | 0.01% | +75.0% |
| Q3 2018 | $42,000 | -51.7% | 13,789 | -50.0% | 0.00% | -42.9% |
| Q2 2018 | $87,000 | -56.7% | 27,589 | -25.4% | 0.01% | -58.8% |
| Q1 2018 | $201,000 | -73.5% | 36,998 | -63.1% | 0.02% | -46.9% |
| Q4 2017 | $758,000 | -56.0% | 100,152 | -52.9% | 0.03% | -50.0% |
| Q3 2017 | $1,722,000 | -24.1% | 212,421 | -13.6% | 0.06% | -22.9% |
| Q2 2017 | $2,268,000 | -43.7% | 245,817 | -34.2% | 0.08% | -50.3% |
| Q1 2017 | $4,028,000 | +172.7% | 373,562 | +261.0% | 0.17% | +209.3% |
| Q4 2016 | $1,477,000 | -28.6% | 103,478 | -66.6% | 0.05% | -41.9% |
| Q3 2016 | $2,068,000 | +58.3% | 310,267 | +328.1% | 0.09% | +38.8% |
| Q2 2016 | $1,306,000 | +10.6% | 72,481 | -23.6% | 0.07% | -14.1% |
| Q1 2016 | $1,181,000 | -68.8% | 94,862 | -40.2% | 0.08% | -63.0% |
| Q4 2015 | $3,784,000 | – | 158,538 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 661,355 | $25,542,000 | 4.19% |
| SECTOR GAMMA AS | 287,850 | $11,117,000 | 3.00% |
| Elk Creek Partners, LLC | 64,685 | $2,498,000 | 1.80% |
| March Altus Capital Management LP | 152,809 | $5,901,000 | 1.79% |
| BRIDGER MANAGEMENT, LLC | 630,000 | $24,331,000 | 1.70% |
| PFM Health Sciences, LP | 2,116,102 | $81,724,000 | 1.64% |
| Partner Investment Management, L.P. | 103,974 | $4,015,000 | 0.91% |
| J. Goldman & Co LP | 185,000 | $7,144,000 | 0.90% |
| WEXFORD CAPITAL LP | 262,600 | $10,142,000 | 0.87% |
| Decatur Capital Management, Inc. | 95,225 | $3,678,000 | 0.71% |